S&P 500   3,798.12 (+0.19%)
DOW   30,400.19 (+0.28%)
QQQ   283.31 (+0.42%)
AAPL   147.10 (+0.68%)
MSFT   250.12 (+0.50%)
META   139.77 (-0.36%)
GOOGL   101.69 (+0.05%)
AMZN   121.47 (+0.31%)
TSLA   241.64 (-3.13%)
NVDA   132.78 (+0.84%)
NIO   16.14 (-3.53%)
BABA   84.75 (+0.76%)
AMD   68.45 (+0.81%)
T   15.98 (-0.68%)
MU   55.16 (+2.22%)
CGC   3.05 (-2.87%)
F   12.55 (+1.54%)
GE   68.12 (+0.86%)
DIS   100.94 (-0.49%)
AMC   7.43 (-5.11%)
PYPL   94.48 (+1.82%)
PFE   44.27 (-0.43%)
NFLX   237.94 (-1.16%)
S&P 500   3,798.12 (+0.19%)
DOW   30,400.19 (+0.28%)
QQQ   283.31 (+0.42%)
AAPL   147.10 (+0.68%)
MSFT   250.12 (+0.50%)
META   139.77 (-0.36%)
GOOGL   101.69 (+0.05%)
AMZN   121.47 (+0.31%)
TSLA   241.64 (-3.13%)
NVDA   132.78 (+0.84%)
NIO   16.14 (-3.53%)
BABA   84.75 (+0.76%)
AMD   68.45 (+0.81%)
T   15.98 (-0.68%)
MU   55.16 (+2.22%)
CGC   3.05 (-2.87%)
F   12.55 (+1.54%)
GE   68.12 (+0.86%)
DIS   100.94 (-0.49%)
AMC   7.43 (-5.11%)
PYPL   94.48 (+1.82%)
PFE   44.27 (-0.43%)
NFLX   237.94 (-1.16%)
S&P 500   3,798.12 (+0.19%)
DOW   30,400.19 (+0.28%)
QQQ   283.31 (+0.42%)
AAPL   147.10 (+0.68%)
MSFT   250.12 (+0.50%)
META   139.77 (-0.36%)
GOOGL   101.69 (+0.05%)
AMZN   121.47 (+0.31%)
TSLA   241.64 (-3.13%)
NVDA   132.78 (+0.84%)
NIO   16.14 (-3.53%)
BABA   84.75 (+0.76%)
AMD   68.45 (+0.81%)
T   15.98 (-0.68%)
MU   55.16 (+2.22%)
CGC   3.05 (-2.87%)
F   12.55 (+1.54%)
GE   68.12 (+0.86%)
DIS   100.94 (-0.49%)
AMC   7.43 (-5.11%)
PYPL   94.48 (+1.82%)
PFE   44.27 (-0.43%)
NFLX   237.94 (-1.16%)
S&P 500   3,798.12 (+0.19%)
DOW   30,400.19 (+0.28%)
QQQ   283.31 (+0.42%)
AAPL   147.10 (+0.68%)
MSFT   250.12 (+0.50%)
META   139.77 (-0.36%)
GOOGL   101.69 (+0.05%)
AMZN   121.47 (+0.31%)
TSLA   241.64 (-3.13%)
NVDA   132.78 (+0.84%)
NIO   16.14 (-3.53%)
BABA   84.75 (+0.76%)
AMD   68.45 (+0.81%)
T   15.98 (-0.68%)
MU   55.16 (+2.22%)
CGC   3.05 (-2.87%)
F   12.55 (+1.54%)
GE   68.12 (+0.86%)
DIS   100.94 (-0.49%)
AMC   7.43 (-5.11%)
PYPL   94.48 (+1.82%)
PFE   44.27 (-0.43%)
NFLX   237.94 (-1.16%)
NASDAQ:CRSP

CRISPR Therapeutics - CRSP Institutional Ownership

$63.97
-1.70 (-2.59%)
(As of 10/5/2022 03:28 PM ET)
Add
Compare
Today's Range
$61.40
$64.96
50-Day Range
$61.10
$81.40
52-Week Range
$42.51
$105.60
Volume
69,982 shs
Average Volume
1.18 million shs
Market Capitalization
$4.99 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$112.33

Institutional Ownership Changes (13F Filings) for CRISPR Therapeutics (NASDAQ:CRSP)

Current
Institutional Ownership
Percentage
70.56%
Number of
Institutional Buyers
(last 12 months)
292
Total
Institutional Inflows
(last 12 months)
$1.41 B
Number of
Institutional Sellers
(last 12 months)
156
Total
Institutional Outflows
(last 12 months)
$400.74 M
Skip Chart & View Institutional Buying and Selling Data

CRSP Institutional Buying and Selling by Quarter

Get CRSP Insider Trade Alerts

Want to know when executives and insiders are buying or selling CRISPR Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


CRISPR Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/12/2022Hussman Strategic Advisors Inc.20,800$1.26M0.2%+100.0%0.027%
8/23/2022Captrust Financial Advisors23,784$1.45M0.0%+13.3%0.030%
8/22/2022Legal & General Group Plc55,306$3.36M0.0%+5.0%0.071%
8/17/2022Macquarie Group Ltd.90,022$5.47M0.0%+4,476.6%0.115%
8/16/2022Oliver Lagore Vanvalin Investment Group2,365$0.14M0.1%+103.0%0.003%
8/16/2022First Republic Investment Management Inc.5,729$0.35M0.0%-23.4%0.007%
8/16/2022Captrust Financial Advisors27,208$1.65M0.0%+29.7%0.035%
8/16/2022RMB Capital Management LLC36,231$2.20M0.1%-9.5%0.046%
8/16/2022International Biotechnology Trust PLC2,078$34K0.4%N/A0.003%
8/16/2022Thrivent Financial for Lutherans21,064$1.28M0.0%+80.3%0.027%
8/16/2022Clough Capital Partners L P317,267$19.28M2.4%+53.9%0.407%
8/16/2022Price T Rowe Associates Inc. MD3,014,551$183.19M0.0%+158.5%3.864%
8/16/2022Creative Planning11,185$0.68M0.0%+8.8%0.014%
8/15/2022AQR Capital Management LLC8,505$0.52M0.0%-6.4%0.011%
8/15/2022State Street Corp1,569,860$95.40M0.0%+228.8%2.012%
8/15/2022Macquarie Group Ltd.90,022$5.47M0.0%+4,476.6%0.115%
8/15/2022PDT Partners LLC26,738$1.63M0.1%+214.6%0.034%
8/15/2022Cubist Systematic Strategies LLC40,492$2.46M0.0%+30.4%0.052%
8/15/2022Atria Wealth Solutions Inc.5,769$0.35M0.0%N/A0.007%
8/15/2022Sei Investments Co.51,685$3.14M0.0%N/A0.066%
8/15/2022Natixis Advisors L.P.17,133$1.04M0.0%-2.3%0.022%
8/15/2022UBS Asset Management Americas Inc.133,154$8.09M0.0%+11.6%0.171%
8/15/2022Alpha Paradigm Partners LLC6,628$0.40M0.2%-67.4%0.008%
8/13/2022Nordea Investment Management AB88,700$5.39M0.0%-8.6%0.114%
8/13/2022Teacher Retirement System of Texas11,432$0.70M0.0%-9.2%0.015%
8/13/2022Virtu Financial LLC56,311$3.42M0.3%+151.4%0.072%
8/13/2022Zeke Capital Advisors LLC34,727$2.11M0.1%+15.3%0.045%
8/13/2022Zurcher Kantonalbank Zurich Cantonalbank 48,205$2.93M0.0%-7.0%0.062%
8/13/2022Wells Fargo & Company MN138,507$8.42M0.0%-29.3%0.178%
8/13/2022Renaissance Technologies LLC568,700$34.56M0.0%-19.0%0.729%
8/12/2022Northern Trust Corp184,231$11.20M0.0%+11.2%0.236%
8/12/2022Virtus ETF Advisers LLC1,784$0.11M0.0%-14.3%0.002%
8/12/2022Ensign Peak Advisors Inc37,169$2.26M0.0%N/A0.048%
8/12/2022LPL Financial LLC72,019$4.38M0.0%+10.2%0.092%
8/12/2022U.S. Capital Wealth Advisors LLC22,571$1.37M0.1%-1.3%0.029%
8/12/2022Credit Suisse AG923,671$56.13M0.1%-9.3%1.184%
8/12/2022Edmond DE Rothschild Holding S.A.3,341$0.20M0.0%N/A0.004%
8/12/2022Rafferty Asset Management LLC59,877$3.64M0.0%+131.5%0.077%
8/12/2022FMR LLC1,619,022$98.39M0.0%+28.3%2.075%
8/12/2022Essex Investment Management Co. LLC12,514$0.76M0.1%-59.4%0.016%
8/12/2022BNP Paribas Arbitrage SA5,469$0.33M0.0%-75.0%0.007%
8/12/2022Axxcess Wealth Management LLC14,078$0.86M0.1%+9.0%0.018%
8/12/2022Franklin Resources Inc.292,646$17.78M0.0%-0.1%0.378%
8/11/2022Cetera Investment Advisers8,064$0.49M0.0%+3.0%0.010%
8/11/2022Cetera Advisor Networks LLC7,932$0.48M0.0%-6.5%0.010%
8/11/2022Perigon Wealth Management LLC11,885$0.72M0.1%+12.9%0.015%
8/11/2022Trexquant Investment LP5,021$0.31M0.0%N/A0.006%
8/11/2022Deutsche Bank AG123,892$7.53M0.0%-0.2%0.159%
8/11/2022Sigma Planning Corp4,767$0.29M0.0%N/A0.006%
8/11/2022UBS Group AG233,919$14.22M0.0%+15.0%0.300%
8/11/2022Bank of Montreal Can4,213$0.31M0.0%-96.5%0.005%
8/11/2022Alps Advisors Inc.45,950$2.79M0.0%N/A0.059%
8/10/20221492 Capital Management LLC12,008$0.73M0.5%N/A0.016%
8/10/2022Cibc World Market Inc.9,378$0.57M0.0%+12.3%0.012%
8/10/2022California Public Employees Retirement System130,304$7.92M0.0%-9.3%0.168%
8/10/2022Montag A & Associates Inc.1,008$61K0.0%-46.0%0.001%
8/9/2022Swiss National Bank172,800$10.50M0.0%+19.4%0.223%
8/9/2022Pictet Asset Management SA423,287$25.72M0.0%+10,753.5%0.546%
8/9/2022SeaCrest Wealth Management LLC1,224$74K0.0%N/A0.002%
8/9/2022Lazard Asset Management LLC264,127$16.05M0.0%+52.5%0.341%
8/8/2022Eqis Capital Management Inc.12,799$0.78M0.1%-29.1%0.017%
8/8/2022Duality Advisers LP47,284$2.87M0.3%+160.5%0.061%
8/8/2022Advisors Asset Management Inc.23,895$1.45M0.0%-13.6%0.031%
8/8/2022Baird Financial Group Inc.3,895$0.24M0.0%N/A0.005%
8/8/2022Oppenheimer & Co. Inc.18,203$1.11M0.0%+6.8%0.024%
8/8/2022Bay Colony Advisory Group Inc d b a Bay Colony Advisors7,370$0.55M0.1%+27.7%0.010%
8/8/2022HC Advisors LLC7,432$0.45M0.3%+2.1%0.010%
8/8/2022Prospera Financial Services Inc1,346$82K0.0%-15.1%0.002%
8/8/2022Antonetti Capital Management LLC1,640$100K0.1%+37.8%0.002%
8/8/2022Banque Pictet & Cie SA12,850$0.78M0.0%-86.5%0.017%
8/5/2022Connor Clark & Lunn Investment Management Ltd.12,211$0.74M0.0%-63.4%0.016%
8/5/2022Nia Impact Advisors LLC45,036$2.74M1.6%-43.8%0.058%
8/5/2022Loomis Sayles & Co. L P1,396,258$84.85M0.2%+8.2%1.803%
8/5/2022Dakota Wealth Management4,487$0.27M0.0%N/A0.006%
8/4/2022Concord Wealth Partners2,873$0.18M0.0%+141.8%0.004%
8/4/2022Steward Partners Investment Advisory LLC1,944$0.12M0.0%+8.2%0.003%
8/4/2022State of New Jersey Common Pension Fund D48,513$2.95M0.0%+6.8%0.063%
8/4/2022Nikko Asset Management Americas Inc.4,584,098$276.05M3.4%-0.8%5.918%
8/4/2022Northwestern Mutual Wealth Management Co.921$56K0.0%+86.8%0.001%
8/4/2022EFG Asset Management North America Corp.79,900$4.86M1.0%+5.0%0.103%
8/4/2022Mitsubishi UFJ Kokusai Asset Management Co. Ltd.4,376$0.27M0.0%+16.2%0.006%
8/4/2022TD Asset Management Inc.103,661$6.30M0.0%+223.7%0.134%
8/3/2022Envestnet Asset Management Inc.21,828$1.33M0.0%+14.3%0.028%
8/3/2022Integral Health Asset Management LLC80,010$4.86M1.0%-33.3%0.103%
8/3/2022Van ECK Associates Corp126,259$7.67M0.0%+10.7%0.163%
8/3/2022Janney Montgomery Scott LLC10,629$0.67M0.0%+5.1%0.014%
8/3/2022AE Wealth Management LLC5,347$0.33M0.0%+29.1%0.007%
8/3/2022Valeo Financial Advisors LLC9,547$0.58M0.0%+7.2%0.012%
8/3/2022FDx Advisors Inc.10,495$0.64M0.0%+22.1%0.014%
8/3/2022Bedell Frazier Investment Counseling LLC34,387$2.09M0.6%+14.2%0.044%
8/3/2022Handelsbanken Fonder AB9,800$0.60M0.0%-3.0%0.013%
8/2/2022Advisory Services Network LLC6,287$0.38M0.0%-53.2%0.008%
8/2/2022Banque Cantonale Vaudoise15,844$0.96M0.0%+274.7%0.020%
8/2/2022Steel Peak Wealth Management LLC7,289$0.44M0.0%-47.2%0.009%
8/2/2022Carnegie Capital Asset Management LLC87,152$5.30M0.2%+1.1%0.113%
8/2/2022Bartlett & Co. LLC5,100$0.31M0.0%-62.5%0.007%
8/2/2022Avantax Advisory Services Inc.6,434$0.39M0.0%+19.7%0.008%
8/2/2022First Horizon Advisors Inc.2,988$0.18M0.0%N/A0.004%
8/1/2022Liberty One Investment Management LLC1,675$0.27M0.0%-58.3%0.002%
8/1/2022Phoenix Wealth Advisors7,750$0.47M0.5%N/A0.010%
(Data available from 1/1/2016 forward)













CRSP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CRSP shares?

During the previous two years, 553 institutional investors and hedge funds held shares of CRISPR Therapeutics. The most heavily invested institutionals were ARK Investment Management LLC ($1.26B), Sumitomo Mitsui Trust Holdings Inc. ($278.58M), Nikko Asset Management Americas Inc. ($276.05M), Capital International Investors ($226.11M), Price T Rowe Associates Inc. MD ($183.19M), BlackRock Inc. ($143.04M), and NEA Management Company LLC ($132.99M).Learn more on CRSP's institutional investors.

What percentage of CRISPR Therapeutics stock is owned by institutional investors?

70.56% of CRISPR Therapeutics stock is owned by institutional investors. Learn more on CRSP's institutional investor holdings.

Which institutional investors have been buying CRISPR Therapeutics stock?

Of the 515 institutional investors that purchased CRISPR Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sumitomo Mitsui Trust Holdings Inc. ($4.62M), Price T Rowe Associates Inc. MD ($1.99M), ARK Investment Management LLC ($1.97M), Nikko Asset Management Americas Inc. ($1.47M), State Street Corp ($1.38M), BlackRock Inc. ($1.36M), and Perceptive Advisors LLC ($1.34M).

How much institutional buying is happening at CRISPR Therapeutics?

Institutional investors have bought a total of 31,071,669 shares in the last 24 months. This purchase volume represents approximately $2.72B in transactions.

Which CRISPR Therapeutics major shareholders have been selling company stock?

Of the 248 institutional investors that sold CRISPR Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Capital International Investors ($3.42M), Versant Venture Management LLC ($3.09M), ARK Investment Management LLC ($2.64M), Two Sigma Advisers LP ($0.68M), Nikko Asset Management Americas Inc. ($0.60M), Price T Rowe Associates Inc. MD ($0.59M), and Clough Capital Partners L P ($0.52M).

How much institutional selling is happening at CRISPR Therapeutics?

Institutional investors have sold a total of 19,140,635 shares in the last 24 months. This volume of shares sold represents approximately $2.28B in transactions.

This page (NASDAQ:CRSP) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.